Literature DB >> 2254798

Assessing quality of life and preferences in the seriously ill using utility theory.

J Tsevat1, N V Dawson, D B Matchar.   

Abstract

Mesh：

Year:  1990        PMID： 2254798     DOI： 10.1016/0895-4356(90)90224-d

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN： 0895-4356            Impact factor:   6.437


× No keyword cloud information.
  6 in total

Review 1.  Relationship between psychometric and utility-based approaches to the measurement of health-related quality of life.

Authors:  D A Revicki; R M Kaplan
Journal:  Qual Life Res       Date:  1993-12       Impact factor: 4.147

2.  Long-term follow-up and individual item analysis of quality of life assessments related to laparoscopic-assisted colectomy in the COST trial 93-46-53 (INT 0146).

Authors:  Chee-Chee H Stucky; Barbara A Pockaj; Paul J Novotny; Jeff A Sloan; Daniel J Sargent; Michael J O'Connell; Robert W Beart; John M Skibber; Heidi Nelson; Jane C Weeks
Journal:  Ann Surg Oncol       Date:  2011-03-31       Impact factor: 5.344

3.  Perioperative patient-reported outcomes predict serious postoperative complications: a secondary analysis of the COST trial.

Authors:  Juliane Bingener; Jeff A Sloan; Paul J Novotny; Barbara A Pockaj; Heidi Nelson
Journal:  J Gastrointest Surg       Date:  2014-08-05       Impact factor: 3.452

Review 4.  Evaluation of quality of life after laparoscopic surgery: evidence-based guidelines of the European Association for Endoscopic Surgery.

Authors:  D Korolija; S Sauerland; S Wood-Dauphinée; C C Abbou; E Eypasch; M García Caballero; M A Lumsden; B Millat; J R T Monson; G Nilsson; R Pointner; W Schwenk; A Shamiyeh; A Szold; E Targarona; B Ure; E Neugebauer
Journal:  Surg Endosc       Date:  2004-04-27       Impact factor: 4.584

5.  Economic methods for measuring the quality of life associated with HIV infection.

Authors:  A M Bayoumi; D A Redelmeier
Journal:  Qual Life Res       Date:  1999-09       Impact factor: 3.440

6.  Subjective health estimations (SHE) in patients with advanced breast cancer: an adapted utility concept for clinical trials.

Authors:  C Hürny; B van Wegberg; M Bacchi; J Bernhard; B Thürlimann; O Real; L Perey; H Bonnefoi; A Coates
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.